CB vs FOLD · P/E 14, rev $59.40B vs rev $528.3M
Chubb Ltd (CB) versus Amicus Therapeutics Inc (FOLD) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
CB currently screens at market cap $114.26B and trailing P/E 13.7. FOLD currently screens at market cap $1.80B.
Not investment advice. Open the CB and FOLD stock pages for the full models.
Not investment advice.